[Whitepaper] Cell and Gene Therapy Commercialization: Mastering the Patient Centric Process

Patients are at the very heart of the cell and gene therapy (CGT) value chain. This key dynamic creates profound implications for production, financial operations, process operations (product ordering, raw material collection, logistics, etc.), and patient access and support.

CGT supply chain mastery starts with a clear understanding of the patient journey and product journey and how these two journeys diverge from processes companies have established to support other modalities.

Download our whitepaper to learn more about:

·       Building processes around the patient

·       Engaging with key stakeholders along the value chain

·       Industrializing processes to increase access

·       Defining the future of cell and gene therapies

Offered Free by: Cardinal Health and Vineti

Download this whitepaper:

© 2021 Questex LLC, All right reserved.

685 Third Avenue, 21st Floor New York, NY 10017

Reproduction in whole or part is prohibited.